Consumer Healthcare Products Association
FDARulemakingFDA-2023-N-2177

Medical Devices; Laboratory Developed Tests

RIN
Last modified
Jul 22, 2025
Comment window
closed 967d ago
Consumer Healthcare Products Association filings
1

Activity

Consumer Healthcare Products Association filed 1 comment on this docket between Nov 17, 2023 and Nov 17, 2023. 2 other organizations filed here. The comment window closed 967d ago.

What Consumer Healthcare Products Association filed (1)

Nov 17, 2023· Comment from Consumer Healthcare Products Association· FDA-2023-N-2177-1944

Comments from the Consumer Healthcare Products Association (CHPA)

Abstract

The Food and Drug Administration is proposing to amend its regulations to make explicit that in vitro diagnostic products (IVDs) are devices under the Federal Food, Drug, and Cosmetic Act including when the manufacturer of the IVD is a laboratory. We are also proposing a policy intended to phase out our general enforcement discretion approach for laboratory developed tests (LDTs) so that IVDs manufactured by laboratories would generally fall under the same enforcement approach as other IVDs. This phaseout is intended to better protect the public health by helping assure the safety and effectiveness of LDTs and may foster innovation.

View on regulations.gov →